106 related articles for article (PubMed ID: 28230929)
1. Investigation of p16 status, chemotherapy regimen, and other nutrition markers for predicting gastrostomy in patients with head and neck cancer.
Brown TE; Wittholz K; Way M; Banks MD; Hughes BG; Lin CY; Kenny LM; Bauer JD
Head Neck; 2017 May; 39(5):868-875. PubMed ID: 28230929
[TBL] [Abstract][Full Text] [Related]
2. Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma.
Dixon PR; Au M; Hosni A; Perez-Ordonez B; Weinreb I; Xu W; Song Y; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
Head Neck; 2016 Sep; 38(9):1347-53. PubMed ID: 27002481
[TBL] [Abstract][Full Text] [Related]
3. Correlation of p16 status, hypoxic imaging using [18F]-misonidazole positron emission tomography and outcome in patients with loco-regionally advanced head and neck cancer.
Trinkaus ME; Hicks RJ; Young RJ; Peters LJ; Solomon B; Bressel M; Corry J; Fisher R; Binns D; McArthur GA; Rischin D
J Med Imaging Radiat Oncol; 2014 Feb; 58(1):89-97. PubMed ID: 24529061
[TBL] [Abstract][Full Text] [Related]
4. Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trial.
Bonner JA; Giralt J; Harari PM; Baselga J; Spencer S; Bell D; Raben D; Liu J; Schulten J; Ang KK; Rosenthal DI
Eur J Cancer; 2016 Sep; 64():1-11. PubMed ID: 27323346
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus E7 serology and association with p16 immunohistochemistry in squamous cell carcinoma of the head and neck.
Khanal S; Joh J; Kwon AM; Zahin M; Perez CA; Dunlap NE; Silverman CL; Tennant PA; Potts KL; Kloecker GH; Bumpous JM; Ghim SJ; Jenson AB; Redman RA
Exp Mol Pathol; 2015 Oct; 99(2):335-40. PubMed ID: 26116154
[TBL] [Abstract][Full Text] [Related]
6. HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours.
Wasserman JK; Rourke R; Purgina B; Caulley L; Dimitroulakos J; Corsten M; Johnson-Obaseki S
J Otolaryngol Head Neck Surg; 2017 Jan; 46(1):3. PubMed ID: 28061890
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of a predictive score for malnutrition in patients treated by irradiation for head and neck cancer: a retrospective study in 127 patients].
Lescut N; Personeni E; Desmarets M; Puyraveau M; Hamlaoui R; Servagi-Vernat S; Bosset JF; Nguyen F
Cancer Radiother; 2013 Nov; 17(7):649-55. PubMed ID: 24183935
[TBL] [Abstract][Full Text] [Related]
8. p16(INK4a) status and survival benefit of EGFR inhibitors in head and neck squamous cell cancer: A systematic review and meta-analysis.
Su Y; Cui J; Xu D; Wang M; Xu T; Tian H; Han F
Crit Rev Oncol Hematol; 2018 Apr; 124():11-20. PubMed ID: 29548481
[TBL] [Abstract][Full Text] [Related]
9. Malnutrition in head and neck cancer patients: Impacts and indications of a prophylactic percutaneous endoscopic gastrostomy.
Yanni A; Dequanter D; Lechien JR; Loeb I; Rodriguez A; Javadian R; Van Gossum M
Eur Ann Otorhinolaryngol Head Neck Dis; 2019 Jun; 136(3S):S27-S33. PubMed ID: 30846293
[TBL] [Abstract][Full Text] [Related]
10. HPV status in patients with head and neck of carcinoma of unknown primary site: HPV, tobacco smoking, and outcome.
Tribius S; Hoffmann AS; Bastrop S; Görögh T; Haag J; Röcken C; Clauditz T; Grob T; Wilczak W; Tennstedt P; Borcherding A; Petersen C; Hoffmann M
Oral Oncol; 2012 Nov; 48(11):1178-84. PubMed ID: 22739067
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of p16 in locally advanced squamous cell carcinoma of the head and neck treated with concurrent cisplatin and radiotherapy.
Lau HY; Brar S; Klimowicz AC; Petrillo SK; Hao D; Brockton NT; Kong CS; Lees-Miller SP; Magliocco AM
Head Neck; 2011 Feb; 33(2):251-6. PubMed ID: 20848448
[TBL] [Abstract][Full Text] [Related]
12. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
[TBL] [Abstract][Full Text] [Related]
13. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
[TBL] [Abstract][Full Text] [Related]
14. HPV-Positive Oropharyngeal Cancer Via p16 Immunohistochemistry in Japan.
Toman J; Von Larson S; Umeno H; Kurita T; Furusaka T; Hasegawa H; Prasad ML; Sasaki CT
Ann Otol Rhinol Laryngol; 2017 Feb; 126(2):152-158. PubMed ID: 27913709
[TBL] [Abstract][Full Text] [Related]
15. p16 expression in cutaneous squamous cell carcinoma of the head and neck is not associated with integration of high risk HPV DNA or prognosis.
Satgunaseelan L; Chia N; Suh H; Virk S; Ashford B; Lum T; Ranson M; Clark J; Gupta R
Pathology; 2017 Aug; 49(5):494-498. PubMed ID: 28663082
[TBL] [Abstract][Full Text] [Related]
16. Poorly differentiated neuroendocrine carcinoma of the head and neck: human papillomavirus tumour status/p16 status and impact on overall survival.
Benzerdjeb N; Traverse-Glehen A; Philouze P; Bishop J; Devouassoux-Shisheboran M
Histopathology; 2020 Mar; 76(4):581-591. PubMed ID: 31463946
[TBL] [Abstract][Full Text] [Related]
17. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
18. p16, HPV, and Cetuximab: What Is the Evidence?
Bonner JA; Mesia R; Giralt J; Psyrri A; Keilholz U; Rosenthal DI; Beier F; Schulten J; Vermorken JB
Oncologist; 2017 Jul; 22(7):811-822. PubMed ID: 28526718
[TBL] [Abstract][Full Text] [Related]
19. p16
Brauswetter D; Birtalan E; Danos K; Kocsis A; Krenacs T; Timar J; Mihalyi R; Horcsik D; Polony G; Tamas L; Petak I
Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1959-1965. PubMed ID: 27999998
[TBL] [Abstract][Full Text] [Related]
20. The relationship between p16 expression and high-risk human papillomavirus infection in squamous cell carcinomas from sites other than uterine cervix: a study of 137 cases.
Doxtader EE; Katzenstein AL
Hum Pathol; 2012 Mar; 43(3):327-32. PubMed ID: 21840041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]